Efficacy and safety of lipid-lowering therapies in combination with or without statin to reduce the cardiovascular risk: A systematic review of randomised controlled trials
Background and aims: Cardiovascular diseases (CVD) pose a significant global health burden.Lowering low-density lipoprotein-cholesterol is the primary therapeutic aim for preventing primary and secondary CVD events.While statins are the standard treatments, their limitations, such as side effects and intolerance in certain patient groups, Bar Spoon